Functional consequences of immune cell adhesion to endothelial cells

Current Pharmaceutical Design

Volumn 10, Issue 2, 2004, Pages 109-120

  Rosemblatt, M ^a   Bono, María Rosa ^b  

^a Fundacion Ciencia para la Vida   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Endothelial activation; High endothelial venules; Lymphocyte activation; Lymphocyte interaction; Vascular endothelium

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; FRACTALKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RANTES;

ANGIOGENESIS; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; B LYMPHOCYTE; CELL ADHESION; CELL CONTACT; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CHEMOTAXIS; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEUKOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE HOMING; MEDICAL RESEARCH; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; CELL ADHESION; CHEMOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, CELLULAR;

EID: 0346025500     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043453487     Document Type: Review

References (140)

1. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
2. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-72.
3. Tangemann K, Gunn MD, Giblin P, Rosen SD. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. J Immunol 1998; 161: 6330-7.
4. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998; 279: 381-4.
5. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
6. Bargatze RF, Butcher EC. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 1993; 178: 367-72.
7. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, et al. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995; 80: 413-22.
8. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 1988; 331: 41-6.
9. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001; 78: 57-110.
10. Homey B, Muller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2002; 2: 175-84.
11. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995; 16: 449-57.
12. Castro A, Bono MR, Simon V, Rosemblatt M. Lymphocyte adhesion to cridothelium derived from human lymphoid tissue. Eur J Cell Biol 1996; 70: 61-8.
13. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
14. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, Gunn MD, et al. The CC chemokine thymus-derived chemotactic agent 4 [TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2] triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000; 191: 61-76.
15. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998; 95: 258-63.
16. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, et al. 6-C-kine [SLC], a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 1998; 141: 1053-9.
17. Baekkevold ES, Yamanaka T, Palframan RT, Carlsen HS, Reinholt FP, von Andrian UH, et al. The CCR7 ligand elc [CCL19] is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 2001; 193: 1105-12.
18. Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998; 188: 181-91.
19. Muller G, Lipp M. Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte Trafficking. Microcirculation 2003; 10: 325-34.
20. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000; 191: 77-88.
21. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, et al. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine [SLC], is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol 1998; 28: 1516-23.
22. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23-33.
23. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002; 196: 65-75.
24. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192: 1553-62.
25. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 1999; 72: 209-53.
26. Bevilacqua MP, Nelson RM. Endothelial-leukocyte adhesion molecules in inflammation and metastasis. Thromb Haemost 1993; 70[1]: 152-4.
27. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13: 106-12.
28. Pals ST, Horst E, Scheper RJ, Meijer CJ. Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol Rev 1989; 108: 111-33.
29. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells [Th1s] and Th2s. J Exp Med 1998; 187: 129-34.
30. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-83.
31. Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 1998; 160: 550-4.
32. Syrbe U, Siveke J, Hamann A. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 1999; 21: 263-85.
33. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998; 161: 547-51.
34. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344-5.
35. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746-54.
36. Ebnet K, Simon MM, Shaw S. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi. Ann N Y Acad Sci 1996; 797: 107-17.
37. Kawai T, Seki M, Hiromatsu K, Eastcott JW, Watts GF, Sugai M, et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol 1999; 163: 3269-78.
38. Marfaing-Koka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995; 154: 1870-8.
39. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, et al. Fractalkine [CX3CL1] as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107: 1173-81.
40. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-30.
41. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-4.
42. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-7.
43. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, et al. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J Leukoc Biol 2000; 67: 577-84.
44. Raychaudhuri SP, Jiang WY, Farber EM. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 2001; 144: 1105-13.
45. Sugaya M, Nakamura K, Mitsui H, Takekoshi T, Saeki H, Tamaki K. Human keratinocytes express fractalkine/CX3CL1. J Dermatol Sci 2003; 31: 179-87.
46. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-9.
47. Mazanet MM, Neote K, Hughes CC. Expression of IFN-inducible T cell alpha chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: implications for cyclosporin A-resistant immune inflammation. J Immunol 2000; 164: 5383-8.
48. Hughes CC, Savage CO, Pober JS. The endothelial cell as a regulator of T-cell function. Immunol Rev 1990; 117: 85-102.
49. +) memory T cells. Cell Immunol 1999; 194: 150-61.
50. Adams PW, Lee HS, Waldman WJ, Sedmak DD, Morgan CJ, Ward JS, et al. Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. J Immunol 1992; 148: 3753-60.
51. + T cells to endothelial cells in the absence of contaminating accessory cells. Transplantation 1994; 57: 1628-37.
52. + allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 1993; 56: 128-34.
53. Savage CO, Brooks CJ, Harcourt GC, Picard JK, King W, Sansom DM, et al. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol 1995; 7: 471-9.
54. Gaspari AA, Jenkins MK, Katz SI. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol 1988; 141: 2216-20.
55. Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J, et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990; 20: 1893-7.
56. Warrens AN, Zhang JY, Sidhu S, Watt DJ, Lombardi G, Sewry CA, et al. Myoblasts fail to stimulate T cells but induce tolerance. Int Immunol 1994; 6: 847-53.
57. Wagner CR, Vetto RM, Burger DR. Subcultured human endothelial cells can function independently as fully competent antigen-prescriting cells. Hum Immunol 1985; 13: 33-47.
58. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998; 10: 525-31.
59. Bromley SK, Dustin ML. Stimulation of naive T-cell adhesion and immunological synapse formation by chemokine-dependent and -independent mechanisms. Immunology 2002; 106: 289-98.
60. + T-cell proliferation. Transplant Proc 2000; 32: 355-6.
61. + T lymphocytes in a 137-dependent fashion. J Immunol 2002; 169: 6154-61.
62. Wagner CR, Vetto RM, Burger DR. The mechanism of antigen presentation by endothelial cells. Immunobiology 1984; 168: 453-69.
63. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-58.
64. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321-31.
65. Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, et al. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 1984; 36: 897-906.
66. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586-90.
67. Lindner H, Holler E, Ertl B, Multhoff G, Schreglmann M, Klauke I, et al. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood 1997; 89: 1931-8.
68. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995; 3: 87-98.
69. Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002; 169: 3581-8.
70. Hughes CC, Savage CO, Pober JS. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990; 171: 1453-67.
71. Karmann K, Pober JS, Hughes CC. Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. J Immunol 1994; 153: 3929-37.
72. Sancho D, Yanez-Mo M, Tejedor R, Sanchez-Madrid F. Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15. Blood 1999; 93(3): 886-96.
73. Rose ML. Endothelial cells as antigen-presenting cells: role in human transplant rejection. Cell Mol Life Sci 1998; 54: 965-78.
74. Pober JS. Immunobiology of human vascular endothelium. Immunol Res 1999; 19: 225-32.
75. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 1985; 135: 3750-62.
76. Marelli-Berg FM, Hargreaves RE, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996; 183: 1603-12.
77. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-9.
78. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chemova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-34.
79. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2001; 2: 203-9.
80. + T cells and is overcome by IL-2. Eur J Immunol 2002; 32: 634-43.
81. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 2001; 98: 13866-71.
82. Pober JS, Doukas J, Hughes CC, Savage CO, Munro JM, Cotran RS. The potential roles of vascular endothelium in immune reactions. Hum Immunol 1990; 28: 258-62.
83. Briscoe DM, DesRoches LE, Kiely JM, Lederer JA, Lichtman AH. Antigen-dependent activation of T helper cell subsets by endothelium. Transplantation 1995; 59: 1638-41.
84. Pober JS, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343-9.
85. St Louis JD, Lederer JA, Lichtman AH. Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy. J Exp Med 1993; 17: 1597-605.
86. Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH. Human endothelial cell costimulation of T cell IFN-gamma production. J Inummol 1997; 159: 3247-56.
87. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993; 14: 335-8.
88. + T cells. J Immunol 1998; 161: 2158-67.
89. + T cells. J Immunol 1999; 162: 696-703.
90. Chambers CA. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001; 22: 217-23.
91. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827-32.
92. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999; 397: 263-6.
93. + T cells. Proc Natl Acad Sci USA 2002; 99: 6198-203.
94. Sherman LA, Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 1993; 11: 385-402.
95. Smith KD, Huczko E, Engelhard VH, Li YY, Lutz CT. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. Transplantation 1997; 64: 351-9.
96. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
97. + T cells. J Immunol 1997; 158: 637-42.
98. Adams PW, Lee HS, Waldman WJ, Sedmak DD, Orosz CG. Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes. Transplantation 1994; 58: 476-83.
99. Epperson DE, Pober JS. Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J Immunol 1994; 153: 5402-12.
100. Meehan SM, McCluskey RT, Pascual M, Preffer FI, Anderson P, Schlossman SF, et al. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 [TIA-1] and cells with fragmented nuclear DNA. Lab Invest 1997; 76: 639-49.
101. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
102. Biedermann BC, Pober JS. Human vascular endotheliall cells favor clonal expansion of unusual alloreactive CTL. J Immunol 1999; 162: 7022-30.
103. Biedermann BC, Pober JS. Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol 1998; 161: 4679-87.
104. + T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000; 164: 5146-55.
105. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984; 38: 293-8.
106. Rose ML, Coles MI, Griffin RJ, Pomerance A, Yacoub MH. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. Transplantation 1986; 41: 776-80.
107. Pober JS, Gimbrone MA, Jr. Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci USA 1982; 79: 6641-5.
108. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984; 81: 4917-21.
109. Watson CA, Petzelbauer P, Zhou J, Pardi R, Bender JR. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and-independent mechanisms. J Immunol 1995; 154: 3222-33.
110. Hall BM, Bishop GA, Duggin GG, Horvath JS, Philips J, Tiller DJ. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 1984; 2: 247-51.
111. + T-cell responses to human allogeneic microvascular endothelium. Circ Res 1991; 69: 1269-79.
112. Pardi R, Bender JR, Engleman EG. Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells. J Immunol 1987; 139: 2585-92.
113. Cresswell P. Chemistry and functional role of the invariant chain. Curr Opin Immunol 1992; 4: 87-92.
114. Naves R, Lennon AM, Barbieri G, Reyes L, Puga G, Salas L, et al. MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator. Int Immunol 2002; 14: 481-91.
115. Lennon AM, Ottone C, Rigaud G, Deaven LL, Longmire J, Fellous M, et al. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 1997; 45: 266-73.
116. Collinge M, Pardi R, Bender JR. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J Immunol 1998; 161: 1589-93.
117. Damle NK, Doyle LV. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome. J Immunol 1989; 142: 2660-9.
118. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T, et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 2000; 164(8): 4055-62.
119. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997; 155: 145-54.
120. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178: 2243-7.
121. Pober JS, Gimbrone MA Jr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, et al. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med 1983; 157: 1339-53.
122. Lienenluke B, Germann T, Kroczek RA, Hecker M. CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 2000; 30: 2864-70.
123. + T cells through a CD2/LFA-3 signaling pathway. Eur J Immunol 1996; 26: 610-7.
124. + T cells and Granulocyte/Macrophage colony-stimulating factor. J Exp Med 1998; 188: 133-43.
125. Cavallo F, Di Carlo E, Butera M, Verrua R, Colombo MP, Musiani P, et al. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res 1999; 59: 414-21.
126. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998; 101: 1441-52.
127. Sunamura M, Sun L, Lozonschi L, Duda DG, Kodama T, Matsumoto G, et al. The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice. Pancreas 2000; 20: 227-33.
128. Strasly M, Cavallo F, Geuna M, Mitola S, Colombo MP, Forni G, et al. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol 2001; 166: 3890-9.
129. Duda DG, Sunamura M, Lozonschi L, Kodama T, Egawa S, Matsumoto G, et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res 2000; 60: 1111-6.
130. Bjerknes M, Cheng H, Ottaway CA. Dynamics of lymphocyte-endothelial interactions in vivo. Science 1986; 231: 402-5.
131. Reyes LI, Escobar P, Bono MR, Rosemblatt M. Adhesion of B cell lines to endothelial cells from human lymphoid tissue modulates tyrosine phosphorylation and endothelial cell activation. J Immunol 2002; 169: 5881-8.
132. Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 1995; 86: 2767-73.
133. Fan ST, Hsia K, Edgington TS. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood 1994; 84: 1567-72.
134. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995; 131: 495-508.
135. Short SM, Talbott GA, Juliano RL. Integrin-mediated signaling events in human endothelial cells. Mol Biol Cell 1998; 9: 1969-80.
136. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, et al. Ligation of CD40 on fibroblasts induces CD54 [ICAM-1] and CD106 [VCAM-1] up-regulation and IL-6 production and proliferation. J Leukoc Biol 1995; 58: 209-16.
137. Xia M, Sreedharan SP, Dazin P, Damsky CH, Goetzl EJ. Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J Cell Biochem 1996; 61: 452-8.
138. Gottlieb D. Cytokine manipulation of the immune response in the treatment of human acute leukaemia. Curr Pharm Design 2002; 8(5): 419-31.
139. Korsgren M. NK cells and asthma. Curr Pharm Design 2002; 8(20): 1871-6.
140. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Design 2002; 8(3): 155-66.